Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Mironov V, Shchugoreva IA, Artyushenko PV, Morozov D, Borbone N, Oliviero G, Zamay TN, Moryachkov RV, Kolovskaya OS, Lukyanenko KA, Song Y, Merkuleva IA, Zabluda VN, Peters G, Koroleva LS, Veprintsev DV, Glazyrin YE, Volosnikova EA, Belenkaya SV, Esina TI, Isaeva AA, Nesmeyanova VS, Shanshin DV, Berlina AN, Komova NS, Svetlichnyi VA, Silnikov VN, Shcherbakov DN, Zamay GS, Zamay SS, Smolyarova T, Tikhonova EP, Chen KH, Jeng US, Condorelli G, de Franciscis V, Groenhof G, Yang C, Moskovsky AA, Fedorov DG, Tomilin FN, Tan W, Alexeev Y, Berezovski MV, Kichkailo AS. Mironov V, et al. Among authors: volosnikova ea. Chemistry. 2022 Feb 24;28(12):e202104481. doi: 10.1002/chem.202104481. Epub 2022 Feb 9. Chemistry. 2022. PMID: 35025110 Free PMC article.
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations.
Shaprova ON, Shanshin DV, Kolosova EA, Borisevich SS, Soroka AA, Merkuleva IA, Nikitin AO, Volosnikova EA, Ushkalenko ND, Zaykovskaya AV, Pyankov OV, Elchaninova SA, Shcherbakov DN, Ilyicheva TN. Shaprova ON, et al. Among authors: volosnikova ea. Antibodies (Basel). 2023 Dec 9;12(4):82. doi: 10.3390/antib12040082. Antibodies (Basel). 2023. PMID: 38131804 Free PMC article.
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF, Shcherbakov DN. Belenkaya SV, et al. Among authors: volosnikova ea. Front Bioeng Biotechnol. 2023 Jun 29;11:1187761. doi: 10.3389/fbioe.2023.1187761. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37456729 Free PMC article.
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Aripov VS, Shanshin DV, Karpenko LI, Belenkaya SV, Kazachinskaia EI, Volosnikova EA, Esina TI, Sergeev AA, Titova KA, Konyakhina YV, Zaykovskaya AV, Pyankov OV, Kolosova EA, Viktorina OE, Shelemba AA, Rudometov AP, Ilyichev AA. Merkuleva IA, et al. Among authors: volosnikova ea. Viruses. 2022 May 16;14(5):1060. doi: 10.3390/v14051060. Viruses. 2022. PMID: 35632800 Free PMC article.
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice.
Volosnikova EA, Merkuleva IA, Esina TI, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Zaykovskaya AV, Pyankov OV, Starostina EV, Zadorozhny AM, Zaitsev BN, Karpenko LI, Ilyichev AA, Danilenko ED. Volosnikova EA, et al. Vaccines (Basel). 2023 Apr 6;11(4):808. doi: 10.3390/vaccines11040808. Vaccines (Basel). 2023. PMID: 37112720 Free PMC article.
Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.
Karpenko LI, Rudometov AP, Sharabrin SV, Shcherbakov DN, Borgoyakova MB, Bazhan SI, Volosnikova EA, Rudometova NB, Orlova LA, Pyshnaya IA, Zaitsev BN, Volkova NV, Azaev MS, Zaykovskaya AV, Pyankov OV, Ilyichev AA. Karpenko LI, et al. Among authors: volosnikova ea. Vaccines (Basel). 2021 Jan 21;9(2):76. doi: 10.3390/vaccines9020076. Vaccines (Basel). 2021. PMID: 33494530 Free PMC article.
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Shanshin DV, Rudometov AP, Karpenko LI, Belenkaya SV, Isaeva AA, Nesmeyanova VS, Kazachinskaia EI, Volosnikova EA, Esina TI, Zaykovskaya AV, Pyankov OV, Borisevich SS, Shelemba AA, Chikaev AN, Ilyichev AA. Merkuleva IA, et al. Among authors: volosnikova ea. Vaccines (Basel). 2022 Jan 9;10(1):96. doi: 10.3390/vaccines10010096. Vaccines (Basel). 2022. PMID: 35062757 Free PMC article.
Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF, Shcherbakov D. Belenkaya SV, et al. Among authors: volosnikova ea. Front Bioeng Biotechnol. 2023 Nov 6;11:1294266. doi: 10.3389/fbioe.2023.1294266. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38026885 Free PMC article.
13 results